ctDNA-guided First-line Immuno-de-escalation Therapy for IVB-stage and Recurrent Cervical Cancer

NCT06878196 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Uterine Cervical Neoplasm

Interventions

DRUG: cadonilimab combined with cisplatin-based chemotherapy ± bevacizumab

Sponsor

Obstetrics & Gynecology Hospital of Fudan University